Switching on a signaling pathway with an organoruthenium complex

Angewandte Chemie - International Edition

Volumn 44, Issue 13, 2005, Pages 1984-1987

  Williams, Douglas S ^a   Atilla, G Ekin ^a   Bregman, Howard ^a   Arzoumanian, Arpine ^a   Klein, Peter S ^a   Meggers, Eric ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bioinorganic chemistry; Enzymes; Medicinal chemistry; Ruthenium; Signal transduction

Indexed keywords

ADENOSINETRIPHOSPHATE; CELLS; CHEMICAL BONDS; COMPLEXATION; ENZYMES;

BINDING SITES; COMPLEXES; ORGANIC MOLECULES; PHENOTYPES;

ORGANOMETALLICS;

ADENOSINE TRIPHOSPHATE; CARBAZOLE DERIVATIVE; ENZYME INHIBITOR; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 ALPHA; ORGANOMETALLIC COMPOUND; PROTEIN KINASE; RUTHENIUM;

ANIMAL; ANIMAL EMBRYO; ARTICLE; CHEMISTRY; DRUG EFFECT; METABOLISM; PHYSIOLOGY; PRENATAL DEVELOPMENT; SIGNAL TRANSDUCTION; SYNTHESIS; XENOPUS LAEVIS;

ADENOSINE TRIPHOSPHATE; ANIMALS; CARBAZOLES; EMBRYO, NONMAMMALIAN; ENZYME INHIBITORS; GLYCOGEN SYNTHASE KINASE 3; ORGANOMETALLIC COMPOUNDS; PROTEIN KINASES; RUTHENIUM; SIGNAL TRANSDUCTION; XENOPUS LAEVIS;

EID: 16844379913     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/anie.200462501     Document Type: Article

References (33)

1. Metal based drugs: a) Chem. Rev. 1999, 99, 2201-2842 (Eds.: C. Orvig, M. J. Abrams); b) Z. Guo, P. Sadler, Angew. Chem. 1999, 111, 1512-1531; Angew. Chem. Int. Ed. 1999, 38, 1512-1531; c) Coord. Chem. Rev. 2002, 232, 1-230 (Ed.: N. Farrell).
2. Metal based drugs: a) Chem. Rev. 1999, 99, 2201-2842 (Eds.: C. Orvig, M. J. Abrams); b) Z. Guo, P. Sadler, Angew. Chem. 1999, 111, 1512-1531; Angew. Chem. Int. Ed. 1999, 38, 1512-1531; c) Coord. Chem. Rev. 2002, 232, 1-230 (Ed.: N. Farrell).
3. Metal based drugs: a) Chem. Rev. 1999, 99, 2201-2842 (Eds.: C. Orvig, M. J. Abrams); b) Z. Guo, P. Sadler, Angew. Chem. 1999, 111, 1512-1531; Angew. Chem. Int. Ed. 1999, 38, 1512-1531; c) Coord. Chem. Rev. 2002, 232, 1-230 (Ed.: N. Farrell).
4. Metal based drugs: a) Chem. Rev. 1999, 99, 2201-2842 (Eds.: C. Orvig, M. J. Abrams); b) Z. Guo, P. Sadler, Angew. Chem. 1999, 111, 1512-1531; Angew. Chem. Int. Ed. 1999, 38, 1512-1531; c) Coord. Chem. Rev. 2002, 232, 1-230 (Ed.: N. Farrell).
5. For bioorganometallic chemistry, see a) K. Severin, R. Bergs, W. Beck, Angew. Chem. 1998, 110, 1722-1743; Angew. Chem. Int. Ed. 1998, 37, 1634-1654; b) D. B. Grotjahn, Coord. Chem. Rev. 1999, 190, 1125-1141; c) J. Organomet. Chem. 1999, 589, 1-126 (Ed.: G. Jaouen); d) N. Metzler-Nolte, Angew. Chem. 2001, 113, 1072-1076; Angew. Chem. Int. Ed. 2001, 40, 1040-1043; e) R. H. Fish, G. Jaouen, Organometallics 2003, 22, 2166-2177; f) R. Stodt, S. Gencaslan, I. M. Müller, W. S. Sheldrick, Eur. J. Inorg. Chem. 2003, 1873-1882.
6. For bioorganometallic chemistry, see a) K. Severin, R. Bergs, W. Beck, Angew. Chem. 1998, 110, 1722-1743; Angew. Chem. Int. Ed. 1998, 37, 1634-1654; b) D. B. Grotjahn, Coord. Chem. Rev. 1999, 190, 1125-1141; c) J. Organomet. Chem. 1999, 589, 1-126 (Ed.: G. Jaouen); d) N. Metzler-Nolte, Angew. Chem. 2001, 113, 1072-1076; Angew. Chem. Int. Ed. 2001, 40, 1040-1043; e) R. H. Fish, G. Jaouen, Organometallics 2003, 22, 2166-2177; f) R. Stodt, S. Gencaslan, I. M. Müller, W. S. Sheldrick, Eur. J. Inorg. Chem. 2003, 1873-1882.
7. For bioorganometallic chemistry, see a) K. Severin, R. Bergs, W. Beck, Angew. Chem. 1998, 110, 1722-1743; Angew. Chem. Int. Ed. 1998, 37, 1634-1654; b) D. B. Grotjahn, Coord. Chem. Rev. 1999, 190, 1125-1141; c) J. Organomet. Chem. 1999, 589, 1-126 (Ed.: G. Jaouen); d) N. Metzler-Nolte, Angew. Chem. 2001, 113, 1072-1076; Angew. Chem. Int. Ed. 2001, 40, 1040-1043; e) R. H. Fish, G. Jaouen, Organometallics 2003, 22, 2166-2177; f) R. Stodt, S. Gencaslan, I. M. Müller, W. S. Sheldrick, Eur. J. Inorg. Chem. 2003, 1873-1882.
8. For bioorganometallic chemistry, see a) K. Severin, R. Bergs, W. Beck, Angew. Chem. 1998, 110, 1722-1743; Angew. Chem. Int. Ed. 1998, 37, 1634-1654; b) D. B. Grotjahn, Coord. Chem. Rev. 1999, 190, 1125-1141; c) J. Organomet. Chem. 1999, 589, 1-126 (Ed.: G. Jaouen); d) N. Metzler-Nolte, Angew. Chem. 2001, 113, 1072-1076; Angew. Chem. Int. Ed. 2001, 40, 1040-1043; e) R. H. Fish, G. Jaouen, Organometallics 2003, 22, 2166-2177; f) R. Stodt, S. Gencaslan, I. M. Müller, W. S. Sheldrick, Eur. J. Inorg. Chem. 2003, 1873-1882.
9. For bioorganometallic chemistry, see a) K. Severin, R. Bergs, W. Beck, Angew. Chem. 1998, 110, 1722-1743; Angew. Chem. Int. Ed. 1998, 37, 1634-1654; b) D. B. Grotjahn, Coord. Chem. Rev. 1999, 190, 1125-1141; c) J. Organomet. Chem. 1999, 589, 1-126 (Ed.: G. Jaouen); d) N. Metzler-Nolte, Angew. Chem. 2001, 113, 1072-1076; Angew. Chem. Int. Ed. 2001, 40, 1040-1043; e) R. H. Fish, G. Jaouen, Organometallics 2003, 22, 2166-2177; f) R. Stodt, S. Gencaslan, I. M. Müller, W. S. Sheldrick, Eur. J. Inorg. Chem. 2003, 1873-1882.
10. For bioorganometallic chemistry, see a) K. Severin, R. Bergs, W. Beck, Angew. Chem. 1998, 110, 1722-1743; Angew. Chem. Int. Ed. 1998, 37, 1634-1654; b) D. B. Grotjahn, Coord. Chem. Rev. 1999, 190, 1125-1141; c) J. Organomet. Chem. 1999, 589, 1-126 (Ed.: G. Jaouen); d) N. Metzler-Nolte, Angew. Chem. 2001, 113, 1072-1076; Angew. Chem. Int. Ed. 2001, 40, 1040-1043; e) R. H. Fish, G. Jaouen, Organometallics 2003, 22, 2166-2177; f) R. Stodt, S. Gencaslan, I. M. Müller, W. S. Sheldrick, Eur. J. Inorg. Chem. 2003, 1873-1882.
11. For bioorganometallic chemistry, see a) K. Severin, R. Bergs, W. Beck, Angew. Chem. 1998, 110, 1722-1743; Angew. Chem. Int. Ed. 1998, 37, 1634-1654; b) D. B. Grotjahn, Coord. Chem. Rev. 1999, 190, 1125-1141; c) J. Organomet. Chem. 1999, 589, 1-126 (Ed.: G. Jaouen); d) N. Metzler-Nolte, Angew. Chem. 2001, 113, 1072-1076; Angew. Chem. Int. Ed. 2001, 40, 1040-1043; e) R. H. Fish, G. Jaouen, Organometallics 2003, 22, 2166-2177; f) R. Stodt, S. Gencaslan, I. M. Müller, W. S. Sheldrick, Eur. J. Inorg. Chem. 2003, 1873-1882.
12. For bioorganometallic chemistry, see a) K. Severin, R. Bergs, W. Beck, Angew. Chem. 1998, 110, 1722-1743; Angew. Chem. Int. Ed. 1998, 37, 1634-1654; b) D. B. Grotjahn, Coord. Chem. Rev. 1999, 190, 1125-1141; c) J. Organomet. Chem. 1999, 589, 1-126 (Ed.: G. Jaouen); d) N. Metzler-Nolte, Angew. Chem. 2001, 113, 1072-1076; Angew. Chem. Int. Ed. 2001, 40, 1040-1043; e) R. H. Fish, G. Jaouen, Organometallics 2003, 22, 2166-2177; f) R. Stodt, S. Gencaslan, I. M. Müller, W. S. Sheldrick, Eur. J. Inorg. Chem. 2003, 1873-1882.
13. L. Zhang, P. J. Carroll, E. Meggers, Org. Lett. 2004, 6, 521-523.
14. H. Bregman, D. S. Williams, G. E. Atilla, P. J. Carroll, E. Meggers, J. Am. Chem. Soc. 2004, 126, 13594-13595.
15. For pioneering work on using chemically inert ruthenium complexes as bioactive compounds in vivo, see a) F. P. Dwyer, E. C. Gyarfas, W. P. Rogers, J. H. Koch, Nature 1952, 170, 190-191; b) F. P. Dwyer, E. C. Gyarfas, R. D. Wright, A. Shulman, Nature 1957, 179, 425-426.
16. For pioneering work on using chemically inert ruthenium complexes as bioactive compounds in vivo, see a) F. P. Dwyer, E. C. Gyarfas, W. P. Rogers, J. H. Koch, Nature 1952, 170, 190-191; b) F. P. Dwyer, E. C. Gyarfas, R. D. Wright, A. Shulman, Nature 1957, 179, 425-426.
17. a) L. M. Toledo, N. B. Lydon, Structure 1997, 5, 1551-1556;
18. b) A. M. Lawrie, M. E. M. Noble, P. Tunnah, N. R. Brown, L. N. Johnson, J. A. Endicott, Nat. Struct. Biol. 1997, 4, 796-801.
19. A related approach was used to synthesize granulatimides: a) T. Yoshida, M. Nishiyachi, N. Nakashima, M. Murase, E. Kotani, Chem. Pharm. Bull. 2002, 50, 872-876; b) T. Yoshida, M. Nishiyachi, N. Nakashima, M. Murase, E. Kotani, Chem. Pharm. Bull. 2003, 51, 209-214.
20. A related approach was used to synthesize granulatimides: a) T. Yoshida, M. Nishiyachi, N. Nakashima, M. Murase, E. Kotani, Chem. Pharm. Bull. 2002, 50, 872-876; b) T. Yoshida, M. Nishiyachi, N. Nakashima, M. Murase, E. Kotani, Chem. Pharm. Bull. 2003, 51, 209-214.
21. A related cyclometalation of 2-pyridylindoles and 2-pyridylpyrroles has been reported: a) R. P. Thummel, V. Hedge, J. Org. Chem. 1989, 54, 1720-1725; b) F. Wu, C. M. Chamchoumis, R. P. Thummel, Inorg. Chem. 2000, 39, 584-590.
22. A related cyclometalation of 2-pyridylindoles and 2-pyridylpyrroles has been reported: a) R. P. Thummel, V. Hedge, J. Org. Chem. 1989, 54, 1720-1725; b) F. Wu, C. M. Chamchoumis, R. P. Thummel, Inorg. Chem. 2000, 39, 584-590.
23. For a review on potent small organic inhibitors of GSK-3, see a) A. Martinez, A. Castro, I. Dorronsoro, M. Alonso, Med. Res. Rev. 2002, 22, 373-384.
24. L. Meijer, A.-L. Skaltsounis, P. Magiatis, P. Polychronopoulos, M. Knockaert, M. Leost, X. P. Ryan, C. A. Vonica, A. Brivanlou, R. Dajani, C. Crovace, C. Tarricone, A. Musacchio, S. M. Roe, L. Pearl, P. Greengard, Chem. Biol. 2003, 10, 1255-1266.
25. J. Witherington, V. Bordas, A. Gaiba, A. Naylor, A. D. Rawlings, B. P. Slingsby, D. G. Smith, A. K. Takle, R. W. Ward, Bioorg. Med. Chem. Lett. 2003, 13, 3059-3062.
26. C. Kunick, K. Lauenroth, M. Leost, L. Meijer, T. Lemcke, Bioorg. Med. Chem. Lett. 2004, 14, 413-416.
27. a) P. J. Morin, BioEssays 1999, 21, 1021-1030;
28. b) P. Cohen, S. Frame, Nat. Rev. Mol. Cell Biol. 2001, 2, 769-776;
29. c) R. S. Jope, G. V. W. Johnson, Trends Biochem. Sci. 2004, 29, 95-102.
30. F. Zhang, C. J. Phiel, L. Spece, N. Gurvich, P. S. Klein, J. Biol. Chem. 2003, 278, 33067-33077.
31. P. S. Klein, D. A. Melton, Proc. Natl. Acad. Sci. USA 1996, 93, 8455-8459.
32. J. Heasman, Development 1997, 124, 4179-4191.
33. W. B. Busa, R. L. Gimlich, Dev. Biol. 1989, 132, 315-324.